SAN JOSE, CA -- (Marketwired) -- 04/23/14 -- Align Technology, Inc. (NASDAQ: ALGN)

• Q1 Net revenues of $180.6 million increased 17.6% year-over-year
• Q1 Invisalign clear aligner net revenues of $168.2 million increased 18.8% year-over-year
• Q1 GAAP earnings per diluted share (EPS) of $0.39
• Board of directors approves $300 million stock repurchase plan

Align Technology, Inc. (NASDAQ: ALGN) today reported financial results for the first quarter ended March 31, 2014. Total net revenues for the first quarter of 2014 (Q1'14) were a record $180.6 million, a 17.6% increase year-over-year. Clear aligner case shipments in Q1'14 were 112.2 thousand, a 14.3% increase year-over-year. GAAP net profit for Q1'14 was $32.4 million, or $0.39 per diluted share, an increase of 52.7% year-over-year or $0.13 per diluted share when compared to non-GAAP net profit.

"We're pleased with our overall first quarter results with better than expected revenue and earnings," said Thomas M. Prescott, Align president and CEO. "Record first quarter revenue increased nearly 18% year-over-year, driven by strong Invisalign volume. This solid growth reflects continued expansion of our customer base, as well as increased adoption and utilization, as doctors treat more patients with Invisalign. Despite numerous global economic challenges, our business remains strong, with growth driven by continued progress in the EMEA and Asia Pacific regions."

Summary Financial Comparisons
(In millions except for shipments and per share amounts)
		Q1'14			Q4'13			Q1'13					Q/Q				Y/Y
GAAP
Clear Aligner Shipments			112,180			111,130			98,175					+0.9	%			+14.3	%
Net Revenues		$	180.6		$	178.3		$	153.6					+1.3	%			+17.6	%
Clear Aligner		$	168.2		$	166.2		$	141.6		1			+1.2	%			+18.8	%
Scanner and Services		$	12.4		$	12.1		$	12.0		2			+2.8	%			+3.3	%
Net Profit (Loss)		$	32.4		$	42.2		$	(42.0	)	3			-23.5	%			+177.3	%
Earnings (Loss) Per Share		$	0.39		$	0.51		$	(0.52	)	3		$	(0.12	)		$	0.91
Non-GAAP
Net Profit		$	32.4		$	42.2		$	21.2					-23.5	%			+52.7	%
Earnings Per Share		$	0.39		$	0.51		$	0.26				$	(0.12	)			+$0.13

Notes:
1.	Q1'13 clear aligner net revenues include $4.4 million from the consolidation of Vivera Retainer product shipments from four shipments per year down to one shipment per year, as well as a $2.7 million decrease in net revenues due to the change in the mid-course correction policy which took effect on June 15, 2013.
2.	Q1'13 scanner and services net revenues includes $1.4 million that was deferred in Q3'12 and Q4'12 for an iTero scanner upgrade program which was launched in Q1'13.
3.	Net loss for Q1'13 includes a goodwill impairment charge of $40.7 million and an impairment of long-lived assets of $26.3 million.

As of March 31, 2014, the Company had $505.4 million in cash, cash equivalents and short-term and long-term marketable securities compared to $472.0 million as of December 31, 2013.

Q2 Fiscal 2014 Business Outlook
For the second quarter of 2014 (Q2'14), Align provides the following guidance:

• Clear aligner case shipments in a range of 116.5 to 119.5 thousand cases.
• Net revenues in a range of $181.7 million to $186.5 million, which reflects a year-over-year increase of 10.9% to 13.8%.
• EPS in a range of $0.36 to $0.39.

Stock Repurchase Plan
In a separate announcement today, Align also announced that its board of directors has authorized a plan to repurchase up to $300 million of the Company's stock over the next three years, with $100 million of that amount authorized and anticipated to be purchased over the next twelve months. The plan is effective immediately. Any purchases under Align's stock repurchase program may be made, from time-to-time, pursuant to S.E.C. 10b5-1 plans, open market purchases, accelerated stock repurchases, privately-negotiated transactions, block trades or derivative contracts or otherwise in accordance with applicable federal securities laws, including Rule 10b-18 of the Securities Exchange Act of 1934. For more information, please see Align's press release titled, "Align Technology Announces $300 Million Stock Repurchase Program."

Align Web Cast and Conference Call
Align Technology will host a conference call today, April 23, 2014 at 4:30 p.m. ET, 1:30 p.m. PT, to review its first quarter 2014 results, discuss future operating trends and the business outlook. The conference call will also be web cast live via the Internet. To access the web cast, go to the "Events & Presentations" section under Company Information on Align Technology's Investor Relations web site at http://investor.aligntech.com. To access the conference call, please dial 201-689-8261 approximately fifteen minutes prior to the start of the call. An archived audio web cast will be available beginning approximately one hour after the call's conclusion and will remain available for approximately 12 months. Additionally, a telephonic replay of the call can be accessed by dialing 877-660-6853 with conference number 13579429 followed by #. For international callers, please dial 201-612-7415 and use the same conference number referenced above. The telephonic replay will be available through 5:30 p.m. ET on April 30, 2014.

Align Technology Analyst Meeting
Align will host an analyst meeting on Thursday, May 29, 2014, from 7:30 - 1:15 p.m. in New York City.

Preliminary Analyst Meeting Schedule (subject to change):
7:00 a.m. Onsite registration
7:30 a.m. -- 8:30 a.m. Management hosted breakfast
8:30 a.m. -- 1:15 p.m. Meeting

Location:
W Union Square
201 Park Avenue South
New York, NY 10003
Phone: 917-534-5805

Registration and Additional Information:
Advanced registration is required for onsite attendance. To register, please use the following link: http://investor.aligntech.com/registration.cfm, or go to our website at http://investor.aligntech.com/ and click on Analyst Meeting 2014.

Align will host a live audio web cast of its analyst meeting via the Internet at http://investor.aligntech.com/. An audio replay of the meeting will also be available via web cast for approximately three months following the meeting at http://investor.aligntech.com/.

About Align Technology, Inc.
Align Technology is the leader in modern clear aligner orthodontics that designs, manufactures and markets the Invisalign system, which provides dental professionals with a range of treatment options for adults and teenagers. The Company also offers the iTero 3D digital scanning system and services for orthodontic and restorative dentistry. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998. Visit www.aligntech.com for more information.

For additional information about Invisalign or to find an Invisalign provider in your area, please visit www.invisalign.com. For additional information about iTero, please visit www.itero.com.

About Non-GAAP Financial Measures
To supplement our consolidated financial statements and our business outlook, we may use from time to time the following non-GAAP financial measures: non-GAAP net profit and non-GAAP earnings per share, which exclude, as applicable, impairment of goodwill, impairment of long-lived assets, acquisition and integration related costs, severance and benefit costs and any related income tax adjustments. The presentation of this financial information is not intended to be considered in isolation, or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP.

We use these non-GAAP financial measures for financial and operational decision making and as a means to evaluate period-to-period comparisons. Our management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our "core operating performance." Management believes that "core operating performance" represents Align's performance in the ordinary, on-going and customary course of its operations. Accordingly, management excludes from "core operating performance" certain expenditures and other items that may not be indicative of our operating performance including discrete cash and non-cash charges that are infrequent, or one-time in nature. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate management's internal evaluation of period-to-period comparisons. We believe these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision making, and (2) they are provided to and used by our institutional investors and the analyst community to facilitate comparisons with prior and subsequent reporting periods. A reconciliation of the GAAP and non-GAAP financial measures for the quarter and year and a more detailed explanation of each non-GAAP financial measure and its uses are provided in the footnotes to the table captioned "Reconciliation of GAAP to non-GAAP Key Financial Metrics" and "Business Outlook Summary" included at the end of this release.

Forward-Looking Statement
This news release, including the tables below, contains forward-looking statements, including statements regarding certain business metrics for the second quarter of 2014, including, but not limited to, anticipated net revenues, gross margin, operating expenses, operating profit, diluted earnings per share, case shipments and cash, cash equivalents and short-term and long-term investments. Forward-looking statements contained in this news release and the tables below relating to expectations about future events or results are based upon information available to Align as of the date hereof. Readers are cautioned that these forward-looking statements are only predictions and are subject to risks, uncertainties and assumptions that are difficult to predict. As a result, actual results may differ materially and adversely from those expressed in any forward-looking statement. Factors that might cause such a difference include, but are not limited to, difficulties predicting customer and consumer purchasing behavior, the willingness and ability of our customers to maintain and/or increase product utilization in sufficient numbers, the possibility that the development and release of new products does not proceed in accordance with the anticipated timeline, the possibility that the market for the sale of these new products may not develop as expected, the risks relating to Align's ability to sustain or increase profitability or revenue growth in future periods while controlling expenses, growth related risks, including capacity constraints and pressure on our internal systems and personnel, our ability to successfully achieve the anticipated benefits from the scanner and services business, continued customer demand for our existing and new products, changes in consumer spending habits as a result of, among other things, prevailing economic conditions, levels of employment, salaries and wages and consumer confidence, the timing of case submissions from our doctors within a quarter, acceptance of our products by consumers and dental professionals, foreign operational, political and other risks relating to Align's international manufacturing operations, Align's ability to protect its intellectual property rights, continued compliance with regulatory requirements, competition from existing and new competitors, Align's ability to develop and successfully introduce new products and product enhancements and the loss of key personnel. These and other risks are detailed from time to time in Align's periodic reports filed with the Securities and Exchange Commission, including, but not limited to, its Annual Report on Form 10-K for the fiscal year ended December 31, 2013, which was filed with the Securities and Exchange Commission on February 28, 2014. Align undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

ALIGN TECHNOLOGY, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
			Three Months Ended
			March 31, 2014			March 31, 2013
Net revenues			$	180,646		$	153,580
Cost of revenues				43,395			40,731
Gross profit				137,251			112,849
Operating expenses:
	Sales and marketing			52,888			42,281
	General and administrative			29,179			30,348
	Research and development			13,380			11,282
	Impairment of goodwill			-			40,693
	Impairment of long-lived assets			-			26,320
Total operating expenses				95,447			150,924
Operating profit (loss)				41,804			(38,075	)
Interest and other income (expense), net				601			(988	)
Profit (loss) before income taxes				42,405			(39,063	)
Provision for income taxes				9,961			2,920
Net profit (loss)			$	32,444		$	(41,983	)
Net profit (loss) per share
- basic			$	0.40		$	(0.52	)
- diluted			$	0.39		$	(0.52	)
Shares used in computing net profit (loss) per share
- basic				81,120			81,248
- diluted				82,817			81,248

ALIGN TECHNOLOGY, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
					March 31, 2014			December 31, 2013
ASSETS
Current assets:
	Cash and cash equivalents				$	182,766		$	242,953
	Marketable securities, short-term					181,674			127,040
	Accounts receivable, net					126,183			113,250
	Inventories					15,840			13,968
	Prepaid expenses and other current assets					43,711			47,465
		Total current assets				550,174			544,676
Marketable securities, long-term						140,932			101,978
Property, plant and equipment, net						79,093			75,743
Goodwill and intangible assets, net						84,388			85,362
Deferred tax assets						22,739			15,766
Other assets						8,315			8,622
			Total assets		$	885,641		$	832,147
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
	Accounts payable				$	18,506		$	17,718
	Accrued liabilities					71,349			80,345
	Deferred revenues					81,000			77,275
		Total current liabilities				170,855			175,338
Other long term liabilities						18,033			22,839
	Total liabilities					188,888			198,177
Total stockholders' equity						696,753			633,970
	Total liabilities and stockholders' equity				$	885,641		$	832,147

ALIGN TECHNOLOGY, INC.
RECONCILIATION OF GAAP TO NON-GAAP KEY FINANCIAL METRICS
Reconciliation of GAAP to Non-GAAP Net Profit			Three Months Ended
(in thousands, except per share amounts)			March 31, 2014			December 31, 2013			March 31, 2013
GAAP Net profit (loss)			$	32,444		$	42,422		$	(41,983	)
	Impairment of goodwill (1)			-			-			40,693
	Impairment of long-lived assets (2)			-			-			26,320
	Income tax-related adjustments (3)			-			-			(3,788	)
Non-GAAP Net profit			$	32,444		$	42,422		$	21,242
Diluted Net profit (loss) per share:
	GAAP		$	0.39		$	0.51		$	(0.52	)
	Non-GAAP		$	0.39		$	0.51		$	0.26
Shares used in computing diluted GAAP Net profit (loss) per share				82,817			82,438			81,248
Shares used in computing diluted Non-GAAP Net profit per share				82,817			82,438			83,003

Notes:
(1) Impairment of goodwill. These costs represent non-cash write-downs of our goodwill generally related to negative trends in market and economic conditions, termination of relationships with distributors, or the increase in competitive environment related to our Scanner and Services reporting unit. We remove the impact of these charges to our operating performance to assist in assessing our ability to generate cash from operations. We believe this may be useful information to users of our financial statements; therefore, we have excluded these charges for purposes of calculating these non-GAAP measures to facilitate an evaluation of our current operating performance, particularly in terms of liquidity.

(2) Impairment of long-lived assets. These costs represent non-cash write-downs of our long-lived assets generally related to the increase in competitive environment related to our Scanner and Services reporting unit. As a result of these conditions, we have assessed that our asset group within the reporting unit was not recoverable and therefore recorded an impairment charge. We remove the impact of these charges to our operating performance to assist in assessing our ability to generate cash from operations. We believe this may be useful information to users of our financial statements; therefore, we have excluded these charges for purposes of calculating these non-GAAP measures to facilitate an evaluation of our current operating performance, particularly in terms of liquidity.

(3) Income tax-related adjustments. Non-GAAP financial information for the quarter is adjusted for a tax rate equal to our annual estimated tax rate on non-GAAP income. This rate is based on our estimated annual GAAP income tax rate forecast, adjusted to account for discrete tax items and items excluded from GAAP income in calculating the non-GAAP financial measures presented above. Our estimated tax rate on non-GAAP income is determined annually and may be re-calculated during the year to take into account events or trends that we believe materially impact the estimated annual rate.

ALIGN TECHNOLOGY, INC.
Q1 2014 FINANCIAL AND BUSINESS METRICS
(in thousands except utilization and doctors trained)
					Q1				Q2				Q3			Q4				FISCAL				Q1
					2013				2013				2013			2013				2013				2014
Invisalign Clear Aligner Net Revenues by Geography:
	North America				$	97,045			$	102,217			$	103,888		$	105,059			$	408,209			$	107,910
	International					31,818				40,320				38,983			50,595				161,716				49,848
	Non-case*					12,709				10,766				10,679			10,570				44,724				10,481
		Total Clear Aligner Net Revenues			$	141,572			$	153,303			$	153,550		$	166,224			$	614,649			$	168,239
			YoY % growth			14.8	%			14.7	%			21.2	%		25.1	%			19.0	%			18.8	%
			QoQ % growth			6.6	%			8.3	%			0.2	%		8.3	%							1.2	%
	*includes Invisalign training, ancillary products, and retainers
Invisalign Clear Aligner Net Revenues by Product:
	Invisalign Full Products				$	112,780			$	123,379			$	125,169		$	136,179			$	497,507			$	138,133
	Invisalign Express Products					16,083				19,158				17,702			19,475				72,418				19,625
	Non-case*					12,709				10,766				10,679			10,570				44,724				10,481
		Total Clear Aligner Net Revenues			$	141,572			$	153,303			$	153,550		$	166,224			$	614,649			$	168,239
Average Invisalign Selling Price (ASP):
	Worldwide ASP (1)				$	1,315			$	1,345			$	1,335		$	1,400			$	1,350			$	1,405
	Worldwide ASP, adjusted (2)				$	1,340			$	1,355			$	1,335		$	1,400			$	1,360			$	1,405
	International ASP				$	1,355			$	1,480			$	1,455		$	1,630			$	1,490			$	1,620
	(1) Invisalign case net revenues / Invisalign case shipments
	(2) Adjusted for one-time adjustments (eg. Q1'13 and Q2'13 grandfathered mid-course correction deferrals)
Invisalign Clear Aligner Cases Shipped by Geography:
	North America					74,730				78,865				80,130			80,120				313,845				81,420
	International					23,445				27,270				26,770			31,010				108,495				30,760
		Total Cases Shipped				98,175				106,135				106,900			111,130				422,340				112,180
Invisalign Clear Aligner Cases Shipped by Product:
	Invisalign Full Products					79,235				84,850				87,670			91,605				343,360				92,335
	Invisalign Express Products					18,940				21,285				19,230			19,525				78,980				19,845
		Total Cases Shipped				98,175				106,135				106,900			111,130				422,340				112,180
Number of Invisalign Doctors Cases Shipped To:
	North America					17,280				18,070				18,140			18,495				27,330				19,015
	International					5,840				6,355				6,510			6,925				10,800				7,185
		Total Doctors Cases Shipped To				23,120				24,425				24,650			25,420				38,130				26,200
Invisalign Doctor Utilization Rates*:
	North America					4.3				4.4				4.4			4.3				11.5				4.3
	North American Orthodontists					8.0				8.0				8.4			8.0				26.4				8.1
	North American GP Dentists					2.9				3.0				2.9			3.0				7.3				2.9
	International					4.0				4.3				4.1			4.5				10.0				4.3
		Total Utilization Rates				4.3				4.4				4.3			4.4				11.1				4.3
	* # of cases shipped/# of doctors to whom cases were shipped
Number of Invisalign Doctors Trained:
	North America					755				1,130				795			1,460				4,140				630
	International					970				1,020				875			1,060				3,925				1255
		Total Doctors Trained Worldwide				1,725				2,150				1,670			2,520				8,065				1,885
		Total to Date Worldwide				78,220				80,370				82,040			84,560				84,560				86,445
Scanner and Services Net Revenues:
	North America Scanner and Services				$	11,952			$	10,454			$	10,875		$	11,980			$	45,261			$	12,313
	International Scanner and Services					56				71				81			88				296				94
		Total Scanner and Net Revenues			$	12,008			$	10,525			$	10,956		$	12,068			$	45,557			$	12,407
Total Net Revenues by Geography:
	Total North America Net Revenues				$	108,997			$	112,671			$	114,763		$	117,039			$	453,470			$	120,223
	Total International Net Revenues					31,874				40,391				39,064			50,683				162,012				49,942
	Total Non-case Net Revenues					12,709				10,766				10,679			10,570				44,724				10,481
		Total Worldwide Net Revenues			$	153,580			$	163,828			$	164,506		$	178,292			$	660,206			$	180,646
			YoY % growth			13.7	%			12.5	%			20.5	%		24.8	%			17.9	%			17.6	%
			QoQ % growth			7.5	%			6.7	%			0.4	%		8.4	%							1.3	%
Stock-based Compensation (SBC)
	SBC included in Gross Profit				$	600			$	600			$	700		$	700			$	2,600			$	800
	SBC included in Operating Expenses					5,800				6,700				6,900			4,500				23,900				8,300
		Total SBC Expense			$	6,400			$	7,300			$	7,600		$	5,200			$	26,500			$	9,100
Note: Historical public data may differ due to rounding. Additionally, rounding may effect totals.

ALIGN TECHNOLOGY, INC.
BUSINESS OUTLOOK SUMMARY
(unaudited)
The outlook figures provided below and elsewhere in this press release are approximate in nature since Align's business outlook is difficult to predict. Align's future performance involves numerous risks and uncertainties and the company's results could differ materially from the outlook provided. Some of the factors that could affect Align's future financial performance and business outlook are set forth under "Forward Looking Information" above in this press release.
Financial Outlook
(in millions, except per share amounts and percentages)
	Q2'14 Guidance
	GAAP
Net Revenues	$181.7 - $186.5
Gross Margin	74.6% - 75.2%
Operating Expenses	$96.8 - $98.7
Operating Margin	21.3% - 22.4%
Net Income per Diluted Share	$0.36 - $0.39*
Business Metrics:	Q2'14
Case Shipments	116.5K - 119.5K
Cash, Cash Equivalents, and Marketable Securities	$545M - $555M*
Capital Expenditure	$13.0M - $15.0M
Depreciation & Amortization	$4.3M - $4.8M
Diluted Shares Outstanding	83.6M*
Stock Based Compensation Expense	$10.8M
Tax Rate	23.0%
* Excludes any stock repurchases during the quarter

Source: Align Technology

News Provided by Acquire Media